CAM
SPPI

Concorde Asset Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Concorde Asset Management’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-14,000
Closed -$84K – 121
2015
Q3 		$84K Hold
14,000
– – 0.14% 93
2015
Q2 		$96K Buy
+14,000
New +$88.9K 0.12% 101

Other funds holding SPPI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Concorde Asset Management's SPPI Position: Q4 2015 in Review

Concorde Asset Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2015, closing a stake of 14,000 shares — an estimated $84K sold.

Concorde Asset Management first reported a position in SPPI in Q2 2015 and held it in 2 quarters. The position peaked at $96K in Q2 2015. 146 funds tracked by Wall St. Rank hold SPPI as of Q4 2015.

  • Concorde Asset Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2015 after selling out during the quarter.
  • Concorde Asset Management sold 14,000 Spectrum Pharmaceuticals Inc shares in Q4 2015, an estimated $84K.
  • Concorde Asset Management first reported a position in Spectrum Pharmaceuticals Inc in Q2 2015 and held it in 2 quarters.
  • Concorde Asset Management's Spectrum Pharmaceuticals Inc position peaked at $96K in Q2 2015.
  • 146 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2015.

Based on Concorde Asset Management's 13F filing for Q4 2015, filed 28 Jan 2016.